Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Gut
|
May 6, 2010
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer
S Ripka, A Neesse, J Riedel, et al.
British Journal of Cancer
|
May 31, 2014
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo
T E Bapiro, K K Frese, A Courtin, et al.
BMC Gastroenterology
|
August 1, 2021
Study protocol P-MAPS: microbiome as predictor of severity in acute pancreatitis-a prospective multicentre translational study
C Ammer-Herrmenau, T Asendorf, G Beyer, et al.
Gut
|
January 13, 2017
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E Hessmann, M S Patzak, L Klein, et al.
British Journal of Cancer
|
May 1, 2020
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma
P G Corrie, W Qian, B Basu, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Gut
|
May 6, 2010
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer
S Ripka, A Neesse, J Riedel, et al.
British Journal of Cancer
|
May 31, 2014
Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo
T E Bapiro, K K Frese, A Courtin, et al.
BMC Gastroenterology
|
August 1, 2021
Study protocol P-MAPS: microbiome as predictor of severity in acute pancreatitis-a prospective multicentre translational study
C Ammer-Herrmenau, T Asendorf, G Beyer, et al.
Gut
|
January 13, 2017
Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
E Hessmann, M S Patzak, L Klein, et al.
British Journal of Cancer
|
May 1, 2020
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma
P G Corrie, W Qian, B Basu, et al.
Page
of 3